Detect cognitive diseases and improve healthcare with digital tools

Diagnosing cognitive disorders and dementia is complicated. A significant proportion of all diagnoses are currently incorrect.

In addition, about 40% of all people with neurodegenerative diseases in Sweden never get diagnosed, thus risk not receiving optimal care.

We can change that, together

Book a demo
Thanks!
×
Oops! Something went wrong. Try again
Book a demo
Thanks!
×
Oops! Something went wrong. Try again
Collaborations within health care

What is Geras Solutions?

Geras Solutions provides a digital tool and decision support for dementia investigation in case of suspected cognitive disease. The tool is developed in collaboration with both health centres and specialist clinics and has been tested clinically by Karolinska University Hospital.

With the help of a tablet, patients and relatives can administer parts of the investigation themselves. The results are interpreted automatically and presented in a separate interface for healthcare.

Cognitive test

The digital tool includes cognitive screening tests performed by the patient at the clinic or home. The test is a further development of traditional paper-and-pen tests (MoCA, MMSE, and clock-test). The tool collects a large amount of data on how the test is conducted and provides cut-off scores to distinguish subjective cognitive impairment, mild cognitive impairment, and suspected cognitive disease/dementia. The test has, in the clinical study, demonstrated higher sensitivity and specificity than other established methods. The time required for tests is also recorded and contributes with additional decision-making documents with limits based on the same clinical study. Every patient is assessed on; memory, visuospatial ability, executive functions, attention/working memory, language, and orientation.

Read more about clinical evidence here.

Medical history

Complete anamnesis with the tool, carried it out, either by the patient himself with the support of a relative, or by healthcare professional. Health professionals determine cross-cutting areas and intelligent question batteries ask supplementary questions. The anamnesis covers: general information about the patient, perceived cognitive symptoms based on each domain, general health status, heredity, medication, mental health, stress, attention span, addiction, risk factors, and lifestyle/habits.

Family History with Neurocognitive Symptom Questionnaire

Relatives can easily contribute with their views on symptom development via the digital version of the neurocognitive symptom questionnaire (CIMP-QUEST). By answering the questions in this well-established framework, a summary generates automatically as an additional basis for decision-making. Ensure consistency by involving relatives and compare the patient's observations to the relatives'. The healthcare interface also provides a reference library with profiles for various cognitive disorders and easily compares them to the patient's profile.

Instant compilation of results

Healthcare professionals can choose which parts of the assessment the patient and relatives should perform. Once these are complete, the results are instantly compiled in the clinical assessment tool for evaluation. Upon patient revisits, compare results without hassle to get a clear picture of progress.

Methods to prevent cognitive impairment and dementia

The FINGER study has revolutionized the approach to brain health. It shows the possibilities of reducing the risk of cognitive impairment by changing lifestyle factors in different risk groups. Via the app " Minnesmottagningen " the patient and relatives have access to a risk reduction tool based on parts of the FINGER study. Here you will find information and support to follow habits related to diet, exercise, social interaction and activities to train the brain.

Benefits for you in health care

Quality
A more comprehensive and accessible decision support, based on validated frameworks, provides the right conditions for improved diagnosis quality.
Capacity
A digitized care flow with improved conditions for patients and relatives to self-administer parts of the investigation, gives more time to care, and enables management of larger patient volumes.
Cost-efficiency
Reduced time spent combined with strengthened opportunities for better assessment, earlier on in the care flow, results in lower costs.

CE marking and patient data management

Geras Solutions provides a CE-marked medical device tool class I, according to MDD (Class IIa according to MDR). We work in a structured manner with quality according to ISO13485. Proper management of patient data is also an important part for us and the healthcare providers who use Geras Solutions tools.
Read more about clinical evidence here.

What others say about Geras Solutions

"With Geras, we have the opportunity to shorten the time of the cognitive assessment process drastically and, at the same time, get access to a much better basis for decision making."
Göran Hagman, Neuropsychologist
Karolinska University Hospital
"In modern health care, cognitive impairment is considered as important as heart failure or other severe disability. Digital tools that the patient himself can access for increased knowledge and self-care are a major advancement as well as validated online tests that can facilitate both diagnostics and early treatment"
Wilhelmina Hoffman, geriatrician, head of the Swedish Dementia Centre
Göran Hagman, Neuropsychologist
Karolinska University Hospital
"With digital support, we have the opportunity to drastically shorten the time of the cognitive investigation process and at the same time gain access to a significantly better basis for decision-making"
"In modern health care, cognitive impairment is considered as important as heart failure or other severe disability. Digital tools that the patient himself can access for increased knowledge and self-care are a major advancement as well as validated online tests that can facilitate both diagnostics and early treatment"
Wilhelmina Hoffman, Geriatrician Swedish Dementia Centre

Latest news

Partners